These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 12611592)

  • 1. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
    Beugnet A; Tee AR; Taylor PM; Proud CG
    Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
    Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cap-dependent translation by insulin-like growth factor-1 in neuronal cells.
    Quevedo C; Salinas M; Alcázar A
    Biochem Biophys Res Commun; 2002 Mar; 291(3):560-6. PubMed ID: 11855825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver.
    Ishiguro H; Katano Y; Nakano I; Ishigami M; Hayashi K; Honda T; Goto H; Bajotto G; Maeda K; Shimomura Y
    Life Sci; 2006 Jul; 79(8):737-43. PubMed ID: 16616211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine and Leucine regulate p70 S6 kinase and 4E-BP1 in intestinal epithelial cells.
    Ban H; Shigemitsu K; Yamatsuji T; Haisa M; Nakajo T; Takaoka M; Nobuhisa T; Gunduz M; Tanaka N; Naomoto Y
    Int J Mol Med; 2004 Apr; 13(4):537-43. PubMed ID: 15010853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
    Vary TC; Lynch CJ
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E631-42. PubMed ID: 16263769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue.
    Lynch CJ; Patson BJ; Anthony J; Vaval A; Jefferson LS; Vary TC
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E503-13. PubMed ID: 12169444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga toxins activate translational regulation pathways in intestinal epithelial cells.
    Colpoys WE; Cochran BH; Carducci TM; Thorpe CM
    Cell Signal; 2005 Jul; 17(7):891-9. PubMed ID: 15763431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
    Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staurosporine inhibits phosphorylation of translational regulators linked to mTOR.
    Tee AR; Proud CG
    Cell Death Differ; 2001 Aug; 8(8):841-9. PubMed ID: 11526437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell hydration and mTOR-dependent signalling.
    Schliess F; Richter L; vom Dahl S; Häussinger D
    Acta Physiol (Oxf); 2006; 187(1-2):223-9. PubMed ID: 16734759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
    Lang CH; Frost RA
    J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism.
    Pellegatta F; Catapano AL; Luzi L; Terruzzi I
    J Cardiovasc Pharmacol; 2006 May; 47(5):643-9. PubMed ID: 16775502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.
    Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ
    J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat.
    Chotechuang N; Azzout-Marniche D; Bos C; Chaumontet C; Gausserès N; Steiler T; Gaudichon C; Tomé D
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1313-23. PubMed ID: 19738034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53.
    Constantinou C; Clemens MJ
    Oncogene; 2005 Jul; 24(30):4839-50. PubMed ID: 15897901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.